68.4801.83% ( -1.280 )
Delay Closed: Nov 16, 16:08:00Overview
GX CN BIOTECH (2820)
The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Und...
- Open
- 69.860
- High
- 71.260
- Low
- 67.680
- Prev. Close
- 69.760
- Volume
- 2.60K
- Turnover
- 178.89K
- Avg Price
- 68.803
- Bid/Ask Ratio
- 25.00%
- Amplitude
- 5.13%
- 52wk High
- 80.000
- Volume Ratio
- 0.09
- Turnover Ratio
- 0.03%
- 52wk Low
- 56.700
- Dividend YieldTTM
- --
- DividendTTM
- --
- NAV
- --
- NAV Date
- --
- Disc/Prem Rate
- --
- Total Issued
- 9.35M
- Assets
- 640.29M
- Min lot size
- 50
- Currency
- HKD
News
Yicai · China Adds Record 51 Innovative Drugs to Public Medical Insurance Catalog
CoinLive · BeiGene to Invest $19.5 Million in Bravera’s Series A Round
PUBT · Akeso's Gumokimab Wins China Approval for Active Ankylosing Spondylitis
PUBT · Akeso Says FDA Complete Response Letter May Explain Unusual Share Price Moves
Market Movers · GenScript Biotech drops 6%
Market Movers · Akeso plunges 25% as FDA declines ivonescimab U.S. approval
